The Gardasil® vaccine—called a “quadrivalent vaccine” because it protects against four HPV types (6, 11, 16, and 18)—was approved by the Food and Drug Administration in 2006 for girls and young women ...

Gardasil is a vaccine, licensed for use in June 2006, by the FDA. It targets four strains of human papillomavirus (HPV) -- HPV-6, 11, 16, and 18. HPV-16 and HPV-18 account for about 70% of all ...

In its rush to market its human papillomavirus vaccine, Merck forgot to make a strong and compelling case for compulsory immunization. Merck's human papillomavirus (HPV) vaccine Gardasil should ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually prevents cancer. That’s because HPV is behind nearly all cervical cancer cases ...

MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to produce the bulk drug substance for its HPV vaccine Gardasil.

The commercial approval in June 2006 of the first HPV vaccine, Gardasil (recombinant HPV subtypes 6/11/16/18), marketed by Whitehouse Station, New Jersey–based Merck, has enabled Ian Frazer to ...

The Gardasil® vaccine—called a “quadrivalent vaccine” because it protects against four HPV types (6, 11, 16, and 18)—was approved by the Food and Drug Administration in 2006 for girls and young women ...